Summary
This prediction ended on 22.11.18 with a price of €62.62. The BUY prediction by tbackenh for Bayer AG performed very badly with a performance of -39.98%. tbackenh has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -5.387% | -5.387% | 70.698% | -9.254% |
| iShares Core DAX® | -1.020% | -1.140% | 1.595% | 50.955% |
| iShares Nasdaq 100 | -2.520% | -5.253% | 26.601% | 82.154% |
| iShares Nikkei 225® | -4.443% | -10.161% | 53.012% | 68.736% |
| iShares S&P 500 | -1.226% | -0.040% | 21.556% | 65.370% |
Comments by tbackenh for this prediction
In the thread Bayer AG diskutieren
Bayer
Wie im Langfristchart erkennbar, bewegte sich die Aktie des Chemie- und Pharma-Riesen von Ende 2011 bis April 2015 stetig aufwärts. Danach folgte eine Abwärtsbewegung. 2017 sehen wir eine kleine, volatilere Auf- und Abwärtsphase. Und genau diese könnte durch die Verteidigung des 256-Tage-GD nun zugunsten einer weiteren Aufwärtsbewegung beendet sein.